Features of blood lipid spectrum correction in patients with non-alcoholic steatohepatitis and type 2 diabetes depending on the stage of diabetic kidney disease.

Abstract

Endothelial dysfunction (ED), the most important factors of which are hyperglycemia, dys- and hyperlipidemia, and atherosclerotic vascular damage, occupies a prominent place in the mechanisms of progression of nonalcoholic steatohepatitis (NASH) and diabetic kidney disease (DKD) in patients with type 2 diabetes mellitus (DM2). The aim of the study. To investigate the effect of the complex of metformin, rosuvastatin, essentiale forte H and quercetin on the state of the lipid spectrum of the blood, which is a factor in the progression of NASH and DKD.